Lilly's Competitive Clinical Research Grant
Lilly's Competitive Clinical Research Grant funds independent clinical research aligned with Eli Lilly and Company's scientific interests through a competitive RFP process.
Funder: Eli Lilly and Company
Due Dates (Anticipated): October 2026 (Full application deadline, projected)
Funding Amounts: Funding varies by project; support may include financial backing and/or study drug provision.
Summary: Supports independent, externally led clinical research projects in areas of Lilly’s scientific interest through a competitive RFP process.
Key Information: This is a forecasted opportunity; deadlines and details may shift—refer to the program page for current information.
Description
Lilly's Competitive Clinical Research Grant is designed to fund external, investigator-initiated clinical research projects that align with Eli Lilly and Company’s scientific priorities. Through a transparent Request for Proposal (RFP) process, independent researchers are invited to submit proposals addressing specific research questions or areas of interest identified by Lilly. Selected projects may receive financial support, study drug supply, or both, as appropriate for the proposed research. Proposals undergo rigorous review by global committees of Lilly medical and scientific staff, and may also involve external expert reviewers, to ensure objective selection. Grantees retain full responsibility for the design, conduct, and regulatory management of their studies.
